Atom Investors’s Sana Biotechnology SANA Stock Holding History

Atom Investors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-30,402	Closed	-$124K	–	820
2025 Q4	$124K	Buy	+30,402	New	+$136K	0.01%	521

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $181B AUM 41.77% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Marex Group London $23.6B AUM 57.16% 1-Year Est. Return

IHAM

Integral Health Asset Management New York $2.53B AUM 154.61% 1-Year Est. Return

Atom Investors's SANA Position: Q1 2026 in Review

Atom Investors sold out of Sana Biotechnology (SANA) in Q1 2026, closing a stake of 30,402 shares — an estimated $124K sold.

Atom Investors first reported a position in SANA in Q4 2025 and held it in 1 quarter. The position peaked at $124K in Q4 2025. 203 funds tracked by Wall St. Rank hold SANA as of Q1 2026.

Atom Investors reported no remaining Sana Biotechnology position as of Q1 2026 after selling out during the quarter.
Atom Investors sold 30,402 Sana Biotechnology shares in Q1 2026, an estimated $124K.
Atom Investors first reported a position in Sana Biotechnology in Q4 2025 and held it in 1 quarter.
Atom Investors's Sana Biotechnology position peaked at $124K in Q4 2025.
203 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2026.

Based on Atom Investors's 13F filing for Q1 2026, filed 15 May 2026.